The latest AI-driven solutions for COVID-19

AI solutions for COVID-19

Date: 20th May 2020

Multiple AI-driven solutions have been announced this week to aid the fight against COVID-19, here are the latest developments; from AI-data management systems, AI-diagnostics to AI-crowd control solutions.

Ataccama, a global provider of AI-powered data management solutions based in Toronto, Canada, have announced their AI-powered data management system for COVID-19 recovery will be made available to governments around the world for free. The ONE platform can quickly integrate, cleanse, and deduplicate data in heterogeneous data landscapes. It will give decision-makers access to real, high quality data, enabling them to make the right decisions, and balance restrictions needed to save lives while reopening the economy as fast as possible.

Behold.ai, a UK-based artificial intelligence radiology company, has announced a partnership with Apollo Hospital Groups in India.  A pilot programme using Behold.ai’s ‘instant triage’ AI-based chest X-ray technology to quickly triage suspected COVID-19 patients, will allow 71 hospitals within the group access to the red dot® algorithm. The ‘instant triage’ will boost India’s efforts in the fight against the COVID-19 pandemic by potentially speeding up diagnosis and ensuring proper allocation of resources.  It is being dubbed the world’s largest deployment of a radiology-based AI diagnostic solution for COVID-19.

Renalytix AI, a commercial-stage artificial intelligence-enabled in vitro diagnostics company, based in New York, US, has announced today a joint venture for scaled production of COVID-19 antibody test kits.  The venture with the Icahn School of Medicine at Mount Sinai and Kantaro Biosciences, will aim to produce more than 10 million tests per month beginning in July.

Today has also seen the announcement by Vivotek Inc, Taiwan, of their new AI-based Crowd Control Solution – designed to enable businesses to comply with social distancing regulations and maintain maximum occupancy as well as a safer and healthier environment during COVID-19.